Related Experiment Video
Updated: Jul 8, 2026

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Published on: June 22, 2016
Hypoxia stimulus: An adaptive immune response during dendritic cell maturation
1Experimental Laboratory of Nephrology and Department of Nephrology, Ciutat Sanitaria i Universitaria de Bellvitge, IDIBELL, Barcelona, Spain. 33981ira@comb.es
Hypoxia drives dendritic cell (DC) differentiation in organ transplantation, activating immune responses. Rapamycin inhibits this process by targeting the hypoxia-inducible factor-1alpha pathway, reducing inflammation.
Area of Science:
- Immunology
- Transplantation Biology
- Cellular Biology
Background:
- The 'injury hypothesis' posits ischemia-reperfusion injury (IRI) drives alloimmune responses in organ transplantation.
- Previous work demonstrated ischemia induces a strong immune/inflammatory response during kidney transplantation.
Purpose of the Study:
- To investigate the role of hypoxia in dendritic cell (DC) differentiation and the immune response during IRI.
- To evaluate the effect of rapamycin on hypoxia-induced DC differentiation and the associated inflammatory pathways.
Main Methods:
- Investigated hypoxia-mediated DC differentiation in vitro, assessing expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and downstream targets.
- Examined the impact of rapamycin on DC differentiation, HIF-1alpha expression, and interleukin-10 secretion.
- Assessed DC-lymphocyte interactions in coculture systems and analyzed DC maturation in IRI mouse kidneys in vivo.
Main Results:
- Hypoxia induced DC differentiation, upregulating HIF-1alpha and its target genes (VEGF, GLUT1).
- Rapamycin dose-dependently attenuated DC differentiation, HIF-1alpha pathway activation, and IL-10 secretion.
- Hypoxia-primed DCs promoted T cell proliferation, an effect blocked by rapamycin. In vivo, rapamycin blunted DC maturation in IRI kidneys.
Conclusions:
- Hypoxia is a key component of the 'injury hypothesis,' promoting DC differentiation and immune activation.
- Rapamycin mitigates the hypoxic immune-inflammatory response by inhibiting the HIF-1alpha pathway, offering a potential therapeutic strategy for IRI.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
Regulation of Angiogenesis and Blood Supply
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Cell-mediated Immune Responses

